sh-DNMT1-transfected cancer cells exhibited a notably reduced tumorigenic ability, as indicated by decreased tumor growth, reduced cell proliferation and augmented cell apoptosis (Fig. 1, E–G; Fig. S1D). This evidence concerns the gene DNMT1 and cancer.